Process Development
Process Development is the systematic design, optimization, and scaling of manufacturing protocols that transform experimental cell and gene therapy products into standardized, reproducible, and clinically viable processes under regulatory-compliant conditions.
328
Publications
15.8K
Citations
1.5K
Authors
453
Institutions
Publications per year
2017–2026
127
328
1–5 of 328
1.5K
11
h-index
7
h-index
6
h-index
6
h-index
6
h-index
1–5 of 1.5K
453
University College London
London, United Kingdom
12 h-index
35 publications
1.2K citations

Clausthal University of Technology
Clausthal-Zellerfeld, Germany
11 h-index
41 publications
1.8K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
9 h-index
33 publications
2.4K citations

Biochemical Society
London, United Kingdom
8 h-index
20 publications
1.1K citations
ETH Zurich
Zurich, Switzerland
7 h-index
27 publications
1.9K citations
Amgen (United States)
Thousand Oaks, United States
7 h-index
40 publications
2.2K citations
Pfizer (United States)
New York, United States
7 h-index
29 publications
6.2K citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
6 h-index
23 publications
1K citations
1–8 of 453
24 publications · 926 citations
19
h-index
20 publications · 1.2K citations
18
h-index
10 publications · 308 citations
9
h-index
8 publications · 577 citations
8
h-index
7 publications · 151 citations
7
h-index
1–5